JSLCX
Price
$12.16
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Net Assets
1.58B
PACAX
Price
$11.04
Change
+$0.01 (+0.09%)
Updated
Aug 8 closing price
Net Assets
568.96M
Interact to see
Advertisement

JSLCX vs PACAX

Header iconJSLCX vs PACAX Comparison
Open Charts JSLCX vs PACAXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv R4
Price$12.16
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.58B
Putnam Dynamic Asset Allocation Cnsrv A
Price$11.04
Change+$0.01 (+0.09%)
VolumeN/A
Net Assets568.96M
JSLCX vs PACAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JSLCX vs. PACAX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSLCX is a Hold and PACAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JSLCX has more cash in the bank: 1.58B vs. PACAX (569M). JSLCX pays higher dividends than PACAX: JSLCX (3.85) vs PACAX (3.66). JSLCX was incepted earlier than PACAX: JSLCX (20 years) vs PACAX (32 years). JSLCX (1.17) is less costly to investors than PACAX (1.00). PACAX is a more actively managed with annual turnover of: 372.00 vs. JSLCX (16.00). JSLCX (0) and PACAX (0) have matching initial minimum investment requirements. JSLCX annual gain was more profitable for investors over the last year : 7.42 vs. PACAX (7.02). PACAX (8.56) and JSLCX (8.43) have equivalent 5 years return.
JSLCXPACAXJSLCX / PACAX
Total Expense Ratio1.071.00107%
Annual Report Gross Expense Ratio1.171.00117%
Fund Existence20 years32 years-
Gain YTD5.5026.07791%
Front LoadN/A6%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B569M278%
Annual Yield % from dividends3.853.66105%
Returns for 1 year7.427.02106%
Returns for 3 years14.7816.4590%
Returns for 5 years8.438.5698%
Returns for 10 years24.6023.38105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLVLY7.820.01
+0.19%
Clinuvel Pharmaceuticals Ltd.
TOIPF1.00N/A
N/A
Thai Oil Public Co., Ltd.
ACITF0.20N/A
N/A
Asian Citrus Holdings Ltd.
OPHRF0.04N/A
N/A
OPHIR METALS CORP.